On January 10th, according to an announcement from Xiao Song Corporation, a recent agreement was signed by the Industry Fund that the company participated in, Huzhou Jinqian Equity Investment Partnership Enterprise (Limited Partnership), to transfer equity in Shenzhen Zhenghe Biotechnology Co., Ltd., a supplier of electronic cigarette vaporizing liquids. Huzhou Jinqian will hold a 20% stake in Zhenghe Biotechnology.
It has been reported that Zhenghe Biologic is an electronic cigarette e-liquid supplier that integrates research and development, production, sales and co-processing services. They have obtained the national tobacco monopoly bureau's "Tobacco monopoly production enterprise license (aerosol production enterprise)".
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
